8 April 2024 in Materials Letters
MBMohammed Mehdi Benmassaoud
Mohammed Mehdi Benmassaoud
+2
26 August 2025 in Sage Open Medical Case Reports
Appendiceal neuroendocrine tumors are a rare subset of well-differentiated neuroendocrine tumors, comprising <1% of all malignancies. Appendiceal cancer is particularly rare, affecting approximately one to two individuals per one million annually in the United States. Appendiceal neuroendocrine tumors have an estimated incidence of 7/100,000 person-years in the United States. In this report, we present the case of a 19-year-old female who arrived to the emergency department with recurrent right lower quadrant pain, unresponsive to initial management for suspected acute appendicitis, and urinary tract infection. Advanced imaging revealed an appendiceal mucocele. The patient underwent appendectomy, and histopathology confirmed a well-differentiated appendiceal neuroendocrine tumor (grade 2) with lymphovascular invasion. A subsequent right hemicolectomy identified metastatic disease in 6 out of 27 lymph nodes. Unfortunately, the patient was lost to follow-up shortly after surgery. This case underscores the diagnostic complexities of appendiceal neuroendocrine tumors, which are often incidental findings during appendectomy and may present with nonspecific or atypical symptoms. It highlights the critical role of tumor size, grade, and histopathological evaluation in guiding management decisions, as well as the importance of a multidisciplinary approach to treatment. Moreover, it emphasizes the necessity of vigilant follow-up, particularly in young patients, to address the long-term implications of this rare malignancy and improve outcomes.
18 July 2025 in Sage Open Medical Case Reports
Bouveret syndrome is a rare complication of gallstone ileus with a high mortality rate. It is defined as the migration of a large gallstone through a cholecystoduodenal fistula leading to gastric outlet obstruction. During this case, gastroenterology was urgently paged to the operating room during an elective cholecystectomy in a 61-year-old female when a large gallstone was found in a fistula. Subsequently, mechanical lithotripsy and basket removal of the stone were performed. This case highlights the importance of swift diagnosis and utility of less-invasive endoscopy procedures for treatment of Bouveret syndrome.
20 October 2026 in Surgical Practice
Objective: To address technical limitations of histotripsy in treating hepatic tumours larger than 3 cm by developing a mathematical framework to optimize treatment coverage while minimizing unsafe overlap. Methodology: A theoretical model was constructed using sphere packing and covering principles to estimate the number of smaller treatment zones required to cover a larger tumour volume and applied to a clinical case of a 6 × 6 cm hepatic tumour. Volume ratios were calculated and adjusted using random close packing density (~64%). Results: Our model predicted 2.16–4.94 treatment zones for a 6 cm tumour; three overlapping treatments were performed to ensure adequate coverage. Our model suggests that the number of required treatments may increase exponentially with tumour size. Conclusions: This framework provides a practical tool for preoperative planning. As tumour size increases, challenges include prolonged procedures, increased anaesthesia exposure and greater resource utilization, especially for tumours exceeding 7 cm. Overlapping treatments may increase risks such as acute kidney injury and vascular thrombosis, necessitating careful patient selection and thorough risk–benefit discussion. Importantly, safety‐limited overlap makes untreated voids within tumours mathematically unavoidable. Thus, our model should not be interpreted as achieving curative intent but can be interpreted as a method for palliative debulking.
13 June 2025 in Sage Open Medical Case Reports
Pancreatic neuroendocrine tumors are an uncommon group of insidious neoplasms that are often diagnosed in the advanced stages. Diagnosing pancreatic neuroendocrine tumors involves proper biopsy technique and immunohistochemistry, while treatments include targeted therapies and systemic chemotherapy. When diagnosed early, patients with localized disease generally have a positive prognosis. We share a case of a 56-year-old man presenting to the emergency department with acute abdominal pain found to have poorly differentiated pancreatic neuroendocrine tumor with metastasis on repeat endoscopic ultrasound-guided fine needle biopsy. Despite multiple treatment changes, sustained tumor presence led to numerous complications and ultimately patient death. This case highlights the nuances and challenges of diagnosing and treating a rare pancreatic neuroendocrine tumor, such as the importance of biopsy technique.
29 July 2026 in Therapeutic Advances in Rare Disease
Background: While somatic mitochondrial dysfunction occurs in diverse cancers, the association between oncogenesis and germline mitochondrial gene pathogenic variants remains unclear. Further, few clinical observations have been reported of cancer occurring in primary mitochondrial disease (PMD) patients. Objectives: To improve understanding of the potential modulating role for PMD gene disorders in cancer prevalence. Design: 727 individuals, including 100 with PMD, from 97 unrelated families were retrospectively surveyed to assess their history of individual cancer occurrence. Methods: We evaluated survey responses by characterizing the cancer prevalence among the study cohort and comparing to the general U.S. population via the National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) database. Odds ratio calculation was performed to determine the association of survey responses and cancer prevalence. Results: Although overall cancer prevalence in PMD probands and their families was elevated compared to the NCI SEER rate (8800 vs 5600 cases per 100,000), odds ratio calculation determined that PMD did not significantly increase the likelihood of developing cancer, with a non-significant trend observed toward less cancer occuring in PMD that needs to be explored in further studies. Cancer prevalence was significantly correlated with advanced age. Significantly reduced prevalence of prostate cancer was seen across the entire cohort. Surprisingly, while low absolute prevalence ( n = 3), a 9-fold increased odds ratio of cancer was seen in POLG patients relative to those with other causes of PMD. Conclusion: No evidence of increased cancer odds was identified in a cohort of PMD patients and their close relatives. Interestingly, a possible inverse association, which did not reach statistical significance, was suggested between mitochondrial disease status and cancer odds. Future prospective investigations in larger PMD kindreds are warranted to validate and evaluate potential mechanistic relations between cancer prevalence and PMD.